MannKind reaches manufacturing milestone with $60M expansion for Tyvaso DPI

MannKind Corporation has scaled-up operations for increased production capacity of Tyvaso DPI, representing a $60 million investment. Construction is ongoing to build out new manufacturing space in Danbury, Connecticut.

“Through MannKind’s partnership with United Therapeutics the current expansion project represents a $60 million investment.”biospace.com

• 1 source
• biospace.comGovernor Ned Lamont to Tour MannKind June 12 as It Reaches a Manufacturing Milestone - BioSpaceAnnalee ArmstrongJun 11, 2023

Summarized from public sources; check the original articles before acting on it.